Kristin Abate Karyopharm Therapeutics Inc. (KPTI) insider trading activity

Kristin Abate is Chief Accounting Officer of Karyopharm Therapeutics Inc.. Currently has a direct ownership of 22,845 shares of KPTI, which is worth approximately $127,475. The most recent transaction as insider was on Oct 15, 2025, when has been sold 12,799 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 22.8K

119.01% 3M change

n/a 12M change

Total Value Held $127,475

Kristin Abate Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Oct 15 2025	BUY Grant, award, or other acquisition	-	12,799 Added 35.91%	22,845 Common Stock
Oct 01 2025	SELL Open market or private sale	$2,280 $6.3 p/Share	362 Reduced 3.48%	10,046 Common Stock
Sep 15 2025	SELL Open market or private sale	$147 $6.43 p/Share	23 Reduced 0.22%	10,408 Common Stock
Sep 12 2025	BUY Grant, award, or other acquisition	-	46 Added 0.44%	10,431 Common Stock
Sep 03 2025	SELL Open market or private sale	$81 $6.78 p/Share	12 Reduced 0.13%	9,463 Common Stock
Jul 22 2025	SELL Open market or private sale	$952 $4.0 p/Share	238 Reduced 2.45%	9,475 Common Stock
Mar 04 2025	SELL Open market or private sale	$3,591 $6.29 p/Share	571 Reduced 5.55%	9,713 Common Stock

Feb 28 2025	BUY Grant, award, or other acquisition	-	933 Added 8.32%	10,284 Common Stock

Kristin Abate

Chief Accounting Officer

Newton, MA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells KPTI shares.

Notify only if

Value

Insider Trading

Get notified when an Karyopharm Therapeutics Inc. insider buys or sells KPTI shares.

Notify only if

Operation

Value

Type

News

Receive news related to Karyopharm Therapeutics Inc.

Track Activities on KPTI

Account